[1]FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors. Retrieved January 9, 2020, from https://www.fda.gov/news-events/press-announcements/fda-appro.....
[1] ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent Loncastuximab Tesirine (ADCT-402) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma，Retrieved J.....
[1] US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma，Retrieved January 21, 2020, from https://www.prnewswire.com/new.....
关注公众号
安卓客户端
